Hanson & Doremus Investment Management’s Eli Lilly LLY Stock Holding History

Hanson & Doremus Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Sell	3,665 -60	-2%	-$60.8K	0.39%	45
2025 Q4	$4M	Sell	3,725 -109	-3%	-$104K	0.48%	34
2025 Q3	$2.92M	Buy	3,834 +1	+0%	+$744	0.37%	46
2025 Q2	$2.99M	Sell	3,833 -7	-0.2%	-$5.44K	0.4%	45
2025 Q1	$3.17M	Buy	3,840 +578	+18%	+$481K	0.46%	42
2024 Q4	$2.52M	Sell	3,262 -145	-4%	-$120K	0.39%	45
2024 Q3	$3.02M	Hold	3,407	–	–	0.48%	39
2024 Q2	$3.08M	Buy	3,407 +7	+0.2%	+$5.6K	0.52%	38
2024 Q1	$2.65M	Buy	3,400 +3	+0.1%	+$2.13K	0.46%	42
2023 Q4	$1.98M	Sell	3,397 -102	-3%	-$59.5K	0.37%	53
2023 Q3	$1.88M	Hold	3,499	–	–	0.39%	54
2023 Q2	$1.64M	Sell	3,499 -16	-0.5%	-$6.71K	0.34%	61
2023 Q1	$1.21M	Sell	3,515 -28	-0.8%	-$9.44K	0.27%	70
2022 Q4	$1.3M	Sell	3,543 -774	-18%	-$274K	0.28%	69
2022 Q3	$1.4M	Sell	4,317 -315	-7%	-$99.8K	0.36%	59
2022 Q2	$1.5M	Hold	4,632	–	–	0.37%	57
2022 Q1	$1.33M	Sell	4,632 -230	-5%	-$59.2K	0.29%	70
2021 Q4	$1.34M	Sell	4,862 -101	-2%	-$25.6K	0.29%	63
2021 Q3	$1.15M	Sell	4,963 -335	-6%	-$82.7K	0.27%	77
2021 Q2	$784K	Buy	5,298 +335	+7%	+$67.3K	0.23%	82
2021 Q1	$927K	Sell	4,963 -65	-1%	-$12.7K	0.21%	92
2020 Q4	$849K	Sell	5,028 -270	-5%	-$40.3K	0.21%	93
2020 Q3	$784K	Hold	5,298	–	–	0.23%	82
2020 Q2	$870K	Sell	5,298 -106	-2%	-$16.3K	0.28%	75
2020 Q1	$750K	Hold	5,404	–	–	0.26%	79
2019 Q4	$710K	Buy	5,404 +347	+7%	+$40.2K	0.2%	98
2019 Q3	$566K	Sell	5,057 -10	-0.2%	-$1.11K	0.18%	105
2019 Q2	$561K	Buy	5,067 +927	+22%	+$109K	0.18%	102
2019 Q1	$537K	Buy	4,140 +137	+3%	+$16.7K	0.18%	107
2018 Q4	$463K	Hold	4,003	–	–	0.17%	110
2018 Q3	$430K	Sell	4,003 -45	-1%	-$4.5K	0.13%	125
2018 Q2	$345K	Hold	4,048	–	–	0.11%	135
2018 Q1	$313K	Hold	4,048	–	–	0.1%	153
2017 Q4	$342K	Hold	4,048	–	–	0.11%	135
2017 Q3	$346K	Hold	4,048	–	–	0.12%	135
2017 Q2	$333K	Sell	4,048 -250	-6%	-$20.4K	0.12%	132
2017 Q1	$362K	Hold	4,298	–	–	0.14%	128
2016 Q4	$316K	Hold	4,298	–	–	0.14%	129
2016 Q3	$345K	Hold	4,298	–	–	0.16%	124
2016 Q2	$338K	Hold	4,298	–	–	0.15%	127
2016 Q1	$309K	Hold	4,298	–	–	0.14%	130
2015 Q4	$362K	Buy	4,298 +431	+11%	+$35.8K	0.16%	123
2015 Q3	$324K	Buy	3,867 +18	+0.5%	+$1.52K	0.16%	129
2015 Q2	$321K	Sell	3,849 -245	-6%	-$18.7K	0.14%	139
2015 Q1	$297K	Hold	4,094	–	–	0.13%	142
2014 Q4	$282K	Hold	4,094	–	–	0.12%	146
2014 Q3	$265K	Hold	4,094	–	–	0.12%	147
2014 Q2	$255K	Hold	4,094	–	–	0.12%	157
2014 Q1	$241K	Sell	4,094 -300	-7%	-$16.7K	0.11%	162
2013 Q4	$224K	Hold	4,394	–	–	0.11%	156
2013 Q3	$221K	Hold	4,394	–	–	0.11%	152
2013 Q2	$216K	Buy	+4,394	New	+$239K	0.12%	146

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hanson & Doremus Investment Management's LLY Position: Q1 2026 in Review

Hanson & Doremus Investment Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $60.8K and leaving 3,665 shares worth $3.37M. The position accounts for 0.39% of the portfolio, ranked #45.

Hanson & Doremus Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Hanson & Doremus Investment Management held 3,665 shares of Eli Lilly worth $3.37M as of Q1 2026.
Hanson & Doremus Investment Management sold 60 Eli Lilly shares in Q1 2026, an estimated $60.8K.
Eli Lilly made up 0.39% of Hanson & Doremus Investment Management's portfolio in Q1 2026, its #45 holding.
Hanson & Doremus Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Hanson & Doremus Investment Management's Eli Lilly position peaked at $4M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2026, filed 17 Apr 2026.